{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:54:28Z","timestamp":1793397268982,"version":"4.5.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.autrev.2016.01.003","type":"journal-article","created":{"date-parts":[[2016,1,8]],"date-time":"2016-01-08T08:18:10Z","timestamp":1452241090000},"page":"375-378","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Pulmonary artery aneurysms in Beh\u00e7et's disease treated with anti-TNF\u03b1: A case series and review of the literature"],"prefix":"10.1016","volume":"15","author":[{"given":"Estee","family":"Chan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirish R.","family":"Sangle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Gerry","family":"Coghlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David D.","family":"D'Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2016.01.003_bb0005","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1056\/NEJM199910213411707","article-title":"Beh\u00e7et's disease","volume":"341","author":"Sakane","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2016.01.003_bb0010","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.autrev.2015.03.008","article-title":"Google-driven search for big data in autoimmune geoepidemiology: analysis of 394827 patients with systemic autoimmune diseases","volume":"14","author":"Ramos-Casals","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2016.01.003_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 Revised International Chapel Hill Consensus Conference nomenclature of vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2016.01.003_bb0020","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/00005792-200301000-00006","article-title":"The long-term mortality and morbidity of beh\u00e7et syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center","volume":"82","author":"Kural-Seyahi","year":"2003","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2016.01.003_bb0025","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.amjmed.2004.05.027","article-title":"Pulmonary artery aneurysms in Beh\u00e7et syndrome","volume":"117","author":"Hamaryudan","year":"2004","journal-title":"Am J Med"},{"key":"10.1016\/j.autrev.2016.01.003_bb0030","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.autrev.2015.02.009","article-title":"The role of infections in Beh\u00e7et disease and neuro-Beh\u00e7et syndrome","volume":"14","author":"Marta","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2016.01.003_bb0035","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.autrev.2014.11.009","article-title":"Beh\u00e7et's syndrome patients exhibit specific microbiome signature","volume":"14","author":"Consolandi","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2016.01.003_bb0040","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1136\/ard.2009.108571","article-title":"Genetics of Beh\u00e7et disease inside and outside the MHC","volume":"69","author":"Meguro","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2016.01.003_bb0045","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.cyto.2003.09.003","article-title":"Cytokine production profile in patients with Beh\u00e7et's disease treated with infliximab","volume":"24","author":"Misumi","year":"2003","journal-title":"Cytokine"},{"key":"10.1016\/j.autrev.2016.01.003_bb0050","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1365-2249.1997.274-ce1159.x","article-title":"Role of \u03b3\u03b4 T lymphocytes in the development of Beh\u00e7et's disease","volume":"107","author":"Yamashita","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2016.01.003_bb0055","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1136\/ard.2005.045195","article-title":"Beh\u00e7et's disease with life-threatening haemoptoe and pulmonary anerusyms: complete remission after infliximab treatment","volume":"65","author":"Baki","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2016.01.003_bb0060","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1007\/s10067-006-0426-8","article-title":"Pulmonary aneurysms and intracardiac thrombi due to Beh\u00e7et's disease in an African\u2013American adolescent with oculocutaneous albinism","volume":"26","author":"Endo","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2016.01.003_bb0065","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s10067-009-1272-2","article-title":"Adlimumab treatment for life threatening pulmonary artery aneurysms in Beh\u00e7et disease: a case report","volume":"29","author":"Lee","year":"2010","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2016.01.003_bb0070","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.semarthrit.2011.02.006","article-title":"Resolution of Beh\u00e7et's syndrome associated pulmonary arterial aneurysms with infliximab","volume":"41","author":"Schreiber","year":"2011","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2016.01.003_bb0075","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/s00296-013-2693-4","article-title":"Efficacy of adalimumab therapy for life-threatening pulmonary vasculitis in Beh\u00e7et's disease","volume":"34","author":"Aamar","year":"2014","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2016.01.003_bb0080","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1002\/art.27568","article-title":"Mortality in Beh\u00e7et's disease","volume":"62","author":"Saadoun","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2016.01.003_bb0085","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/rheumatology\/kei257","article-title":"Treatment of Beh\u00e7et's syndrome","volume":"45","author":"Barnes","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2016.01.003_bb0090","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1136\/ard.2004.034231","article-title":"Prevalence of the antiphospholipid syndrome in primary systemic vasculitis","volume":"65","author":"Rees","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2016.01.003_bb0095","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1080\/03009740252937630","article-title":"Catastrophic antiphospholipid syndrome in a patient with Beh\u00e7et's disease","volume":"31","author":"Famularo","year":"2002","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.autrev.2016.01.003_bb0100","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/acr.21557","article-title":"Beh\u00e7et's disease: successful treatment with infliximab in 7 patients with severe vascular manifestations. A retrospective analysis","volume":"64","author":"Adler","year":"2012","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.autrev.2016.01.003_bb0105","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.autrev.2014.01.056","article-title":"Biotherapies in Beh\u00e7et's disease","volume":"13","author":"Comarmond","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2016.01.003_bb0110","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1177\/2040622314523062","article-title":"Update on the therapy of Beh\u00e7et disease","volume":"5","author":"Saleh","year":"2014","journal-title":"Ther Adv Chronic Dis"},{"key":"10.1016\/j.autrev.2016.01.003_bb0115","first-page":"98","article-title":"Short-term trial of etanercept in Beh\u00e7et's disease: a double blind, placebo controlled study","volume":"32","author":"Melikoglu","year":"2005","journal-title":"J Rheumatol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997216000045?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997216000045?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,16]],"date-time":"2018-09-16T08:55:44Z","timestamp":1537088144000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997216000045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S1568997216000045"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2016.01.003","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pulmonary artery aneurysms in Beh\u00e7et's disease treated with anti-TNF\u03b1: A case series and review of the literature","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2016.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}